Gilead Sciences (GILD)
(Delayed Data from NSDQ)
$65.27 USD
-1.81 (-2.70%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $65.09 -0.18 (-0.28%) 7:58 PM ET
4-Sell of 5 4
B Value D Growth F Momentum C VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 27% (69 out of 251)Zacks Sector Rank
Top 19% (3 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.24 | 1.35 | 9.99 |
Current Quarter Estimate | -1.49 | 7.43 | 60.00 |
Year Ago Quarter Estimate | 1.37 | 0.12 | 52.54 |
Next Quarter Estimate | 1.61 | 7.81 | 61.00 |
Next Year Estimate | 7.27 | 37.76 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -37.50 | 12.90 | 17.08 |
Next Year | 73.10 | 8.30 | 8.00 |
Last 5 Years | -0.70 | 1.00 | 8.10 |
Next 5 Years | 13.30 | 19.90 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 9.98 | -2.18 |
Price/Book (MRQ) | 3.67 | 2.01 |
Price/Cash Flow (MRFY) | 7.50 | 14.08 |
Dividend Yield | 4.59% | 0.00% |
Net Profit Margin (TTM) | 20.89% | -100.99% |
Return on Equity (TTM) | 38.85% | -55.59% |
Debt to Equity (MRQ) | NA | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.